Skip to main content

Table 6 Efficacy of a single oral dose of Simparica Trio™ and afoxolaner+ milbemycin oxime against natural infestations with Ixodes ricinus, Rhipicephalus sanguineus, Dermacentor reticulatus and Ixodes hexagonus on dogs presented as veterinary patients in Europe

From: Efficacy of a novel oral chewable tablet containing sarolaner, moxidectin and pyrantel (Simparica Trio™) against natural flea and tick infestations on dogs presented as veterinary patients in Europe

Treatment group

Study day

I. ricinus

R. sanguineus

D. reticulatus

I. hexagonus

Mean tick count

% Efficacy

Mean tick count

% Efficacy

Mean tick count

% Efficacy

Mean tick count

% Efficacy

Simparica Trio™

− 1 or 0

3.5

13.7

1.8

1.0

7 ± 2

0.1

99.1

1.1

96.6

0

100

0

100

14 ± 2

0.1

98.8

0.8

93.9

0

100

0

100

21 ± 2

0.1

99.1

0.2

97.2

0

100

0

100

30 ± 4

0

100.0

0.2

97.0

0

100

0

100

Afoxolaner + Milbemycin oxime

− 1 or 0

3.3

15.3

2.0

2.7

7 ± 2

0.3

95.2

0.9

97.8

0

100

0

100

14 ± 2

0.1

96.9

0.6

97.9

0

100

0

100

21 ± 2

0.1

96.4

0.1

99.3

0

100

0

100

30 ± 4

0

99.5

0.3

99.1

0

100

0

100

  1. Notes: Before treatment administration (on study day − 1 or 0) the number of dogs in the Simparica Trio™ and afoxolaner + milbemycin oxime groups infected with each species was 71 and 35 for I. ricinus, 60 and 30 for R. sanguineus, 28 and 16 for D. reticulatus and 3 and 3 for I. hexagonus, respectively